Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - COST OF REVENUE
Cost of Revenue DNLI - Denali Therapeutics Inc.
16.7 M
LAST VALUE
72.68%
2 YEAR CAGR
17.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR